Big lineup of healthcare stocks crack Russell 3000® Index |
 |
 |
| By M.E.Garza |
| Tuesday, 30 June 2009 06:56 |
 It’s official, the new list of Russell 3000® stocks has been unveiled and a big lineup of healthcare sector companies who were looking to bring value to their shareholders and expose their stocks to a broader base of institutional investors have succeeded. Certainly, speaking to the growth of the sector was the fact that nearly six times more stocks were added to the list from the BioMed/Healthcare segment of the market than were deleted. The Russell 3000® Index measures the performance of the largest 3000 U.S. companies representing approximately 98% of the investable U.S. equity market and serves as the U.S. component to the Russell Global Index. Getting included in the new list is a big deal for many of these companies and their investors because these Russell indexes are widely used by investment managers and institutionals for index funds and as benchmarks for both passive and active investment strategies. It is estimated that $4 trillion in assets are currently benchmarked to Russell indexes. "It means they are on the radar screens of money managers who have to replicate the Russell 2000 or Russell 3000," says Steve Claiborne, a spokesman for Russell, adding that smaller companies commonly highlight their inclusion. "It's a bit of good news for them." The following healthcare sector stocks were added to the index: Allied Healthcare International Inc.(NASDAQ:AHCI) Allion Healthcare, Inc.(NASDAQ:ALLI) American Caresource Holdings, Inc.(NASDAQ:ANCI) American Dental Partners, Inc.(NASDAQ:ADPI) ARYx Therapeutics, Inc.(NASDAQ:ARYX) Aspect Medical Systems, Inc.(NASDAQ:ASPM) ATS Medical, Inc.(NASDAQ:ATSI) AVANIR Pharmaceuticals(NASDAQ:AVNR) AVI BioPharma, Inc.(NASDAQ:AVII) BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) BioDelivery Sciences International, Inc.(NASDAQ:BDSI) BioScrip Inc.(NASDAQ:BIOS) BioSpecifics Technologies Corp.(NASDAQ:BSTC) Bovie Medical Corporation(AMEX:BVX) Cardiovascular Systems, Inc.(NASDAQ:CSII) Cardium Therapeutics Inc.(AMEX:CXM) Cell Therapeutics, Inc.(NASDAQ:CTIC) Chelsea Therapeutics International Ltd.(NASDAQ:CHTP) China-Biotics Inc.(NASDAQ:CHBT) Clarient, Inc.(NASDAQ:CLRT) Continucare Corporation(AMEX:CNU) Cornerstone Therapeutics, Inc.(NASDAQ:CRTX) Curis, Inc.(NASDAQ:CRIS) Cutera, Inc.(NASDAQ:CUTR) Delcath Systems, Inc.(NASDAQ:DCTH) Electro-Optical Sciences, Inc.(NASDAQ:MELA) Endologix, Inc.(NASDAQ:ELGX) EnteroMedics Inc.(NASDAQ:ETRM) Harvard Bioscience, Inc.(NASDAQ:HBIO) HeartWare International, Inc.(NASDAQ:HTWR) Hemispherx BioPharma, Inc(AMEX:HEB) Hi-Tech Pharmacal Co.(NASDAQ:HITK) Home Diagnostics, Inc.(NASDAQ:HDIX) Impax Laboratories, Inc.(NASDAQ:IPXL) Insmed Incorporated(NASDAQ:INSM) Lannett Company, Inc.(AMEX:LCI) LCA-Vision Inc.(NASDAQ:LCAV) MAKO Surgical Corp.(NASDAQ:MAKO) Matrixx Initiatives, Inc.(NASDAQ:MTXX) MedQuist Inc.(NASDAQ:MEDQ) Medifast, Inc.( NYSE:MED) Merge Healthcare Inc.(NASDAQ:MRGE) Metropolitan Health Networks, Inc.(AMEX:MDF) Micromet Inc.(NASDAQ:MITI) NeurogesX, Inc(NASDAQ:NGSX) NovaMed, Inc.(NASDAQ:NOVA) OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI) OXiGENE, Inc.(NASDAQ:OXGN) Poniard Pharmaceuticals, Inc.(NASDAQ:PARD) Repros Therapeutics Inc.(NASDAQ:RPRX) Rochester Medical Corporation(NASDAQ:ROCM) Rockwell Medical Technologies, Inc.(NASDAQ:RMTI) SciClone Pharmaceuticals, Inc.(NASDAQ:SCLN) SIGA Technologies, Inc.(NASDAQ:SIGA) Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) StemCells, Inc.(NASDAQ:STEM) SuperGen, Inc.(NASDAQ:SUPG) Utah Medical Products, Inc.(NASDAQ:UTMD) Vanda Pharmaceuticals Inc.(NASDAQ:VNDA) Vical Incorporated(NASDAQ:VICL) Vision-Sciences, Inc.(NASDAQ:VSCI) Young Innovations, Inc.(NASDAQ:YDNT) The following healthcare sector stocks were deleted from the index: Alexza Pharmaceuticals, Inc.( NASDAQ:ALXA) BioForm Medical, Inc.(NASDAQ:BFRM) Caliper Life Sciences Inc.(NASDAQ:CALP) Cell Genesys, Inc.(NASDAQ:CEGE) Columbia Laboratories Inc.(NASDAQ:CBRX) Five Star Quality Care, Inc.(AMEX:FVE) Jazz Pharmaceuticals, Inc.(NASDAQ:JAZZ) Marshall Edwards, Inc.(NASDAQ:MSHL) Rexahn Pharmaceuticals, Inc.(AMEX:RNN) Targacept , Inc.(NASDAQ:TRGT) XOMA Limited(NASDAQ:XOMA) The newly reconstituted list can be found here: http://www.russell.com/indexes/documents/Membership/Russell3000_Membership_List_2009.pdf The total returns data for the Russell Indexes are available here: http://www.russell.com/Indexes/performance/default.asp BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section Add this page to your favorite Social Bookmarking websites            |
about 2 hours ago
A Stem-Cell-Based Drug Gets Approval in Canada $OSIR http://t.co/XI3gAfMY
about 3 hours ago
$JNJ Zytiga, a Prostate Cancer Drug, Does Well in Trial http://t.co/v7YUm9b6
about 5 hours ago
$PFE Pfizer Lung Drug Stops Deadly Child Cancers in Study | http://t.co/hcfdrnCY
about 5 hours ago
Human Genome Looks to Anyone but GlaxoSmithKline | http://t.co/d4IMkIn3
about 6 hours ago
When David Einhorn did not mention Herbalife $HLF as a potential short candidate, that stock shot up on Wednesday | http://t.co/XpFKihQS
about 7 hours ago
Stock Market: Stocks Get Hammered On Disappointing Data, Greece Worries http://t.co/FyH8zpru
about 8 hours ago
Synergy Pharmaceuticals (SGYP) May Be Ready To Roll - Small Cap Stock Market Investing Tips http://t.co/FHYXlF1Q
about 10 hours ago
Alvine Presents Results from Phase 2A Trial of ALV003 in Celiac Disease Patients -2012 Digestive Diseases Week Meeting http://t.co/e6Rjhbj9
Free Phone Trade Alerts
